pentoxifylline has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 3 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline was added after incubation of normal cells with patient serum, and the directed chemotaxis was restored." | 1.28 | Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment. ( Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM, 1992) |
| "Pentoxifylline (PTX) is a non-toxic methylxanthine used clinically for the treatment of intermittent claudication." | 1.28 | Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro. ( Advani, S; Chitnis, M; Juvekar, A; Viladkar, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kido, M | 1 |
| Tago, O | 1 |
| Fujiwara, H | 1 |
| Ito, M | 1 |
| Niwano, H | 1 |
| Fossat, C | 1 |
| Sainty, D | 1 |
| Stoppa, AM | 1 |
| Maraninchi, D | 1 |
| Juhan-Vague, I | 1 |
| Viladkar, A | 1 |
| Juvekar, A | 1 |
| Chitnis, M | 1 |
| Advani, S | 1 |
3 other studies available for pentoxifylline and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.
Topics: Alprostadil; Antineoplastic Agents; Humans; Hydroxyurea; Leg Ulcer; Leukemia, Myelogenous, Chronic, | 1998 |
Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.
Topics: Bacteremia; Bone Marrow Transplantation; Cells, Cultured; Chemotaxis, Leukocyte; Disease Susceptibil | 1992 |
Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
Topics: Doxorubicin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Leukemia, Myelogeno | 1991 |